302 results
Page 3 of 16
8-K
EX-99.1
ta0 uzglg3y4nl1gapk
25 Feb 21
Caladrius Biosciences Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
4:07pm
8-K
EX-99.2
5g6agruhi
25 Feb 21
Caladrius Biosciences Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
4:07pm
424B5
pwiyuuc98s6gq 7071c
16 Feb 21
Prospectus supplement for primary offering
4:49pm
424B5
qj9zxe
16 Feb 21
Prospectus supplement for primary offering
4:46pm
8-K
EX-99.1
k6n qbgqu
29 Jan 21
Regulation FD Disclosure
7:58am
8-K
EX-99.1
jzr9anrngixn
25 Jan 21
Caladrius Biosciences Announces $25.0 Million Private Placement
4:01pm
8-K
EX-99.1
gxtylw5
11 Jan 21
Regulation FD Disclosure
4:07pm
8-K
EX-99.1
xm0a 6todzuni685
14 Dec 20
Regulation FD Disclosure
8:04am
8-K
EX-99.2
wsbg d82fuxzwttkd8
14 Dec 20
Regulation FD Disclosure
8:04am
8-K
EX-99.1
7h5vm84
17 Nov 20
Caladrius Biosciences Announces the Resignation of Dr. Douglas Losordo, Chief Medical Officer
4:06pm
8-K
EX-99.1
rg2ncnzy
5 Nov 20
Caladrius Biosciences Provides Corporate Update and Reports 2020 Third Quarter Financial Results
4:09pm
8-K
EX-99.2
e586zv4cwdzyk
5 Nov 20
Caladrius Biosciences Provides Corporate Update and Reports 2020 Third Quarter Financial Results
4:09pm
424B3
v65wz bwc
2 Sep 20
Prospectus supplement
4:03pm
8-K
EX-99.1
lxmcp30a57musq7504
13 Aug 20
Caladrius Biosciences Provides Corporate Update and Reports 2020 Second Quarter Financial Results
4:08pm